John Senatore, DPM
Podiatrist · Towson, MDNPI 1679510762
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,366 of the $6,158 with a category attached, or 70.9%. Heron Therapeutics, Inc. accounts for 90.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $4,617 and has fallen 91.7% since, to $383 in 2025.
Across 34 payments — averaging $181.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heron Therapeutics, Inc.$6K
- Amgen$360
- Treace Medical Concepts, Inc.$93
- Paragon 28, Inc.$60
- Dynasplint Systems Inc.$38
- Supreme Orthopedic Systems, LLC$17
What the payments were for
- Consulting fees$1,05017%
- Speaking & faculty fees$4,36671%
- Food & beverage$74212%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heron Therapeutics, Inc. | 11 | $5,591 |
| Amgen | 15 | $360 |
| Treace Medical Concepts, Inc. | 5 | $93 |
| Paragon 28, Inc. | 1 | $60 |
| Dynasplint Systems Inc. | 1 | $38 |
| Supreme Orthopedic Systems, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zynrelef$5,416
How this compares
$6,158 in reported general payments places this provider in the 85th percentile of 183 podiatrist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 54 | $1,356 |
| Cephalexin | 16 | $482 |
| Terbinafine Hcl | 22 | $428 |
| Clotrimazole | 16 | $135 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Towson
- Ijeoma NwujuBethesda$601K
- David Linla Plata$75K
- Ira GottliebPasadena$25K
- Teresa HilliardHyattsville$19K
- Andreas KaikisHagerstown$17K
- Tiffany HohBaltimore$17K
- Shashank SrivastavaFrederick$15K
- Hayden HofflerCatonsville$15K
- Enzo LeonePasadena$15K
- Holly BeckSilver Spring$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.